320 related articles for article (PubMed ID: 15044556)
21. Functional interaction among opioid receptor types: up-regulation of mu- and delta-opioid receptor functions after repeated stimulation of kappa-opioid receptors.
Khotib J; Narita M; Suzuki M; Yajima Y; Suzuki T
Neuropharmacology; 2004 Mar; 46(4):531-40. PubMed ID: 14975677
[TBL] [Abstract][Full Text] [Related]
22. Chronic pain induces anxiety with concomitant changes in opioidergic function in the amygdala.
Narita M; Kaneko C; Miyoshi K; Nagumo Y; Kuzumaki N; Nakajima M; Nanjo K; Matsuzawa K; Yamazaki M; Suzuki T
Neuropsychopharmacology; 2006 Apr; 31(4):739-50. PubMed ID: 16123756
[TBL] [Abstract][Full Text] [Related]
23. Depression of C fibre-evoked spinal field potentials by the spinal delta opioid receptor is enhanced in the spinal nerve ligation model of neuropathic pain: involvement of the mu-subtype.
Buesa I; Urrutia A; Aira Z; Salgueiro M; Bilbao J; Mozas M; Aguilera L; Zimmermann M; Azkue JJ
Neuropharmacology; 2008 Dec; 55(8):1376-82. PubMed ID: 18775732
[TBL] [Abstract][Full Text] [Related]
24. Morphine withdrawal syndrome and its prevention with baclofen: Autoradiographic study of mu-opioid receptors in prepubertal male and female mice.
Diaz SL; Barros VG; Antonelli MC; Rubio MC; Balerio GN
Synapse; 2006 Aug; 60(2):132-40. PubMed ID: 16715492
[TBL] [Abstract][Full Text] [Related]
25. An experimental itch model in monkeys: characterization of intrathecal morphine-induced scratching and antinociception.
Ko MC; Naughton NN
Anesthesiology; 2000 Mar; 92(3):795-805. PubMed ID: 10719958
[TBL] [Abstract][Full Text] [Related]
26. The unconditioned fear produced by morphine withdrawal is regulated by mu- and kappa-opioid receptors in the midbrain tectum.
De Ross J; Avila MA; Ruggiero RN; Nobre MJ; Brandão ML; Castilho VM
Behav Brain Res; 2009 Dec; 204(1):140-6. PubMed ID: 19520121
[TBL] [Abstract][Full Text] [Related]
27. Central opioid receptors mediate morphine-induced itch and chronic itch via disinhibition.
Wang Z; Jiang C; Yao H; Chen O; Rahman S; Gu Y; Zhao J; Huh Y; Ji RR
Brain; 2021 Mar; 144(2):665-681. PubMed ID: 33367648
[TBL] [Abstract][Full Text] [Related]
28. The central versus peripheral antinociceptive effects of μ-opioid receptor agonists in the new model of rat visceral pain.
Al-Khrasani M; Lackó E; Riba P; Király K; Sobor M; Timár J; Mousa S; Schäfer M; Fürst S
Brain Res Bull; 2012 Feb; 87(2-3):238-43. PubMed ID: 22079588
[TBL] [Abstract][Full Text] [Related]
29. Selective and interactive down-regulation of mu- and delta-opioid receptors in human neuroblastoma SK-N-SH cells.
Baumhaker Y; Gafni M; Keren O; Sarne Y
Mol Pharmacol; 1993 Aug; 44(2):461-7. PubMed ID: 8394999
[TBL] [Abstract][Full Text] [Related]
30. Anti-exudative effects of opioid receptor agonists in a rat model of carrageenan-induced acute inflammation of the paw.
Romero A; Planas E; Poveda R; Sánchez S; Pol O; Puig MM
Eur J Pharmacol; 2005 Mar; 511(2-3):207-17. PubMed ID: 15792790
[TBL] [Abstract][Full Text] [Related]
31. Electrophysiological demonstration of mu, delta and kappa opioid receptors in the ventral pallidum.
Mitrovic I; Napier TC
J Pharmacol Exp Ther; 1995 Mar; 272(3):1260-70. PubMed ID: 7891342
[TBL] [Abstract][Full Text] [Related]
32. Characterization of scratching behavior induced by intradermal administration of morphine and fentanyl in mice.
Yamamoto A; Kuyama S; Kamei C; Sugimoto Y
Eur J Pharmacol; 2010 Feb; 627(1-3):162-6. PubMed ID: 19900440
[TBL] [Abstract][Full Text] [Related]
33. Inhibitory effects of TRK-820 on systemic skin scratching induced by morphine in rhesus monkeys.
Wakasa Y; Fujiwara A; Umeuchi H; Endoh T; Okano K; Tanaka T; Nagase H
Life Sci; 2004 Oct; 75(24):2947-57. PubMed ID: 15454345
[TBL] [Abstract][Full Text] [Related]
34. Kappa-opioid receptor-mediated antinociception in the rat. II. Supraspinal in addition to spinal sites of action.
Millan MJ; Członkowski A; Lipkowski A; Herz A
J Pharmacol Exp Ther; 1989 Oct; 251(1):342-50. PubMed ID: 2571723
[TBL] [Abstract][Full Text] [Related]
35. Mechanism of clocinnamox blockade of opioid receptors: evidence from in vitro and ex vivo binding and behavioral assays.
Zernig G; Burke T; Lewis JW; Woods JH
J Pharmacol Exp Ther; 1996 Oct; 279(1):23-31. PubMed ID: 8858971
[TBL] [Abstract][Full Text] [Related]
36. Role of delta-opioid receptor function in neurogenesis and neuroprotection.
Narita M; Kuzumaki N; Miyatake M; Sato F; Wachi H; Seyama Y; Suzuki T
J Neurochem; 2006 Jun; 97(5):1494-505. PubMed ID: 16696856
[TBL] [Abstract][Full Text] [Related]
37. Interactions among mu- and delta-opioid receptors, especially putative delta1- and delta2-opioid receptors, promote dopamine release in the nucleus accumbens.
Hirose N; Murakawa K; Takada K; Oi Y; Suzuki T; Nagase H; Cools AR; Koshikawa N
Neuroscience; 2005; 135(1):213-25. PubMed ID: 16111831
[TBL] [Abstract][Full Text] [Related]
38. Antinociceptive effects of nociceptin/orphanin FQ administered intrathecally in monkeys.
Ko MC; Naughton NN
J Pain; 2009 May; 10(5):509-16. PubMed ID: 19231294
[TBL] [Abstract][Full Text] [Related]
39. Delta opioid receptor enhancement of mu opioid receptor-induced antinociception in spinal cord.
He L; Lee NM
J Pharmacol Exp Ther; 1998 Jun; 285(3):1181-6. PubMed ID: 9618421
[TBL] [Abstract][Full Text] [Related]
40. Cross-talk between Human Spinal Cord μ-opioid Receptor 1Y Isoform and Gastrin-releasing Peptide Receptor Mediates Opioid-induced Scratching Behavior.
Liu XY; Ginosar Y; Yazdi J; Hincker A; Chen ZF
Anesthesiology; 2019 Aug; 131(2):381-391. PubMed ID: 31314749
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]